Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity

Dendritic cells (DCs) promote immune responses to foreign Ags and immune tolerance to self-Ags. Deregulation of DCs is implicated in autoimmunity, but the molecules that regulate DCs to protect against autoimmunity have remained unknown. In this study, we show that mice lacking the protein tyrosine...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 188; no. 11; pp. 5397 - 5407
Main Authors Kaneko, Tetsuya, Saito, Yasuyuki, Kotani, Takenori, Okazawa, Hideki, Iwamura, Hiroko, Sato-Hashimoto, Miho, Kanazawa, Yoshitake, Takahashi, Satoshi, Hiromura, Keiju, Kusakari, Shinya, Kaneko, Yoriaki, Murata, Yoji, Ohnishi, Hiroshi, Nojima, Yoshihisa, Takagishi, Kenji, Matozaki, Takashi
Format Journal Article
LanguageEnglish
Published United States 01.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dendritic cells (DCs) promote immune responses to foreign Ags and immune tolerance to self-Ags. Deregulation of DCs is implicated in autoimmunity, but the molecules that regulate DCs to protect against autoimmunity have remained unknown. In this study, we show that mice lacking the protein tyrosine phosphatase Shp1 specifically in DCs develop splenomegaly associated with more CD11c(+) DCs. Splenic DCs from the mutant mice showed upregulation of CD86 and CCR7 expression and of LPS-induced production of proinflammatory cytokines. The mice manifested more splenic Th1 cells, consistent with the increased ability of their DCs to induce production of IFN-γ by Ag-specific T cells in vitro. The number of splenic CD5(+)CD19(+) B-1a cells and the serum concentrations of Igs M and G2a were also increased in the mutant mice. Moreover, aged mutant mice developed glomerulonephritis and interstitial pneumonitis together with increased serum concentrations of autoantibodies. Shp1 is thus a key regulator of DC functions that protects against autoimmunity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.1103210